51 – 60 of 110
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures
(
- Contribution to journal › Article
-
Mark
Characterization and Visualization of Vesicles in the Endo-Lysosomal Pathway with Surface-Enhanced Raman Spectroscopy and Chemometrics
(
- Contribution to journal › Article
-
Mark
Hippocampal dysfunction defines disease onset in Huntington's disease
(
- Contribution to journal › Article
-
Mark
Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Advancing pharmacotherapy for treating Huntington's disease : a review of the existing literature
(
- Contribution to journal › Article
-
Mark
Comparative epidemiology of incident Parkinson's disease in Cambridgeshire, UK
(
- Contribution to journal › Article
-
Mark
A simple assessment model to quantifying the dynamic hippocampal neurogenic process in the adult mammalian brain
(
- Contribution to journal › Article
-
Mark
Gray and white matter imaging : A biomarker for cognitive impairment in early Parkinson's disease?
(
- Contribution to journal › Article
-
Mark
GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease : involvement of astrocyte-neuron interactions
(
- Contribution to journal › Article
-
Mark
Are Stem Cell-Based Therapies for Parkinson's Disease Ready for the Clinic in 2016?
(
- Contribution to journal › Article